Moreover, Ding et al. reported that combination therapy with nivolumab and IFN-γ shows a synergistic effect on PD-1 blockade compared with IFN-γ or nivolumab alone in pancreatic cancer [25]. The gene discussed is IFNG; the disease is familial pancreatic carcinoma.